Dirlotapide, a U.S. Food and Drug Administration-approved first-in-class obesity drug for dogs-will humans be next?

J Diabetes Sci Technol. 2007 May;1(3):314-6. doi: 10.1177/193229680700100301.
No abstract available

Keywords: MTP inhibitors; dirlotapide; dogs; obesity; selective microsomal triglyceride transfer protein inhibitors.

Publication types

  • Editorial